MFW
TEVA icon

Mosaic Family Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

Mosaic Family Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-250
Closed -$4K – 902
2017
Q3 		$4K Buy
+250
New +$5.63K ﹤0.01% 762
2016
Q3 		– Sell
-159
Closed -$8K – 782
2016
Q2 		$8K Sell
159
-171
-52% -$9.1K ﹤0.01% 552
2016
Q1 		$17K Buy
330
+54
+20% +$3.17K 0.01% 463
2015
Q4 		$18K Buy
+276
New +$17.1K 0.01% 465

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Mosaic Family Wealth's TEVA Position: Q4 2017 in Review

Mosaic Family Wealth sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 250 shares — an estimated $4K sold.

Mosaic Family Wealth first reported a position in TEVA in Q4 2015 and held it in 4 quarters. The position peaked at $18K in Q4 2015. 507 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Mosaic Family Wealth reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Mosaic Family Wealth sold 250 Teva Pharmaceuticals shares in Q4 2017, an estimated $4K.
  • Mosaic Family Wealth first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • Mosaic Family Wealth's Teva Pharmaceuticals position peaked at $18K in Q4 2015.
  • 507 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Mosaic Family Wealth's 13F filing for Q4 2017, filed 13 Feb 2018.